Testing effectiveness (Phase 2)WithdrawnNCT05535023
What this trial is testing
Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell Carcinoma
Who this might be right for
Squamous Cell CarcinomaOropharynx CancerHead and Neck Cancer
M.D. Anderson Cancer Center